Open AccessThis article is
- freely available
Trust in Vaccines: Why It Takes More than Good Faith
Chief Medical Officer, GlaxoSmithKline Vaccines, Avenue Fleming, 1300 Wavre, Belgium
Received: 29 May 2013; in revised form: 21 June 2013 / Accepted: 10 July 2013 / Published: 12 August 2013
Abstract: This Vaccines issue on “Confidence in Vaccines” provides sound evidence through multiple perspectives of life-saving impacts when vaccination programs are effectively implemented in a population. Yet there remain challenges to achieving this impact, including scientific, medical, manufacturing, policy-related and logistical issues. Additionally, socio-cultural, religious and political agendas can come into play, taking public health hostage and sometimes allowing the circulation of myths regarding vaccination. All of these challenges play a role in public confidence in vaccines and vaccination. What we trust, we embrace. What we do not trust, we do not embrace.
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Begg, N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines 2013, 1, 343-347.
Begg N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines. 2013; 1(3):343-347.
Begg, Norman. 2013. "Trust in Vaccines: Why It Takes More than Good Faith." Vaccines 1, no. 3: 343-347.